Cargando…

Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China

BACKGROUND: The present study aimed to estimate residents’ willingness to accept a future H7N9 vaccine and its determinants in the general adult population in Beijing, China. METHODS: We conducted a multi-stage sampling, cross-sectional survey using self-administered anonymous questionnaires from Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shuangsheng, Su, Jianting, Yang, Peng, Zhang, Haiyan, Li, Hongjun, Chu, Yanhui, Hua, Weiyu, Li, Chao, Tang, Yaqing, Wang, Quanyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115431/
https://www.ncbi.nlm.nih.gov/pubmed/29246476
http://dx.doi.org/10.1016/j.vaccine.2017.12.008
_version_ 1783514095936339968
author Wu, Shuangsheng
Su, Jianting
Yang, Peng
Zhang, Haiyan
Li, Hongjun
Chu, Yanhui
Hua, Weiyu
Li, Chao
Tang, Yaqing
Wang, Quanyi
author_facet Wu, Shuangsheng
Su, Jianting
Yang, Peng
Zhang, Haiyan
Li, Hongjun
Chu, Yanhui
Hua, Weiyu
Li, Chao
Tang, Yaqing
Wang, Quanyi
author_sort Wu, Shuangsheng
collection PubMed
description BACKGROUND: The present study aimed to estimate residents’ willingness to accept a future H7N9 vaccine and its determinants in the general adult population in Beijing, China. METHODS: We conducted a multi-stage sampling, cross-sectional survey using self-administered anonymous questionnaires from May to June, in 2014. The main outcome variable was residents’ willingness to accept a future H7N9 vaccine. Logistic regression was used to identify the predictors of vaccination willingness. RESULTS: Of the 7264 eligible participants, 14.5% of Beijing residents reported that they had not heard of H7N9. Among those who had heard of H7N9, 59.5% of the general adult population would be willing to accept a future H7N9 vaccine, and approximately half of them reported ‘I am afraid of being infected by H7N9’ and ‘H7N9 vaccine can prevent infections’, and 28.1% reported ‘my daily life is affected by H7N9’. The variables that were significantly associated with a higher likelihood of reporting willingness were being younger adults (aged 18–29 years: OR = 1.52, 95% CI: 1.17–1.97; aged 30–39 years: OR = 1.39, 95% CI: 1.08–1.78), being farmers (OR = 1.61; 95% CI: 1.32–1.96), being unemployed people (OR = 1.36; 95% CI: 1.04–1.78), living in suburban areas (OR = 2.18; 95% CI: 1.89–2.51), having ≥2 children in the family (OR = 1.41; 95% CI: 1.03–1.92), perceived risk in China (OR = 1.30; 95% CI: 1.15–1.48), perceived susceptibility to disease (OR = 3.13; 95% CI: 2.73–3.58), perceived negative effect on daily life (OR = 1.32; 95% CI: 1.13–1.55), perceived effectiveness of vaccination (OR = 2.34; 95% CI: 2.07–2.64), and recent uptake of influenza vaccine (OR = 2.26; 95% CI: 1.92–2.66). CONCLUSIONS: A great number of Beijing residents had doubts about the vaccine’s effectiveness and were not concerned about disease risk, which were the factors affecting willingness to be vaccinated. Targeted education programs on disease risk as well as vaccine’s effectiveness are needed to improve the willingness of vaccination for potential H7N9 pandemic preparedness.
format Online
Article
Text
id pubmed-7115431
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71154312020-04-02 Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China Wu, Shuangsheng Su, Jianting Yang, Peng Zhang, Haiyan Li, Hongjun Chu, Yanhui Hua, Weiyu Li, Chao Tang, Yaqing Wang, Quanyi Vaccine Article BACKGROUND: The present study aimed to estimate residents’ willingness to accept a future H7N9 vaccine and its determinants in the general adult population in Beijing, China. METHODS: We conducted a multi-stage sampling, cross-sectional survey using self-administered anonymous questionnaires from May to June, in 2014. The main outcome variable was residents’ willingness to accept a future H7N9 vaccine. Logistic regression was used to identify the predictors of vaccination willingness. RESULTS: Of the 7264 eligible participants, 14.5% of Beijing residents reported that they had not heard of H7N9. Among those who had heard of H7N9, 59.5% of the general adult population would be willing to accept a future H7N9 vaccine, and approximately half of them reported ‘I am afraid of being infected by H7N9’ and ‘H7N9 vaccine can prevent infections’, and 28.1% reported ‘my daily life is affected by H7N9’. The variables that were significantly associated with a higher likelihood of reporting willingness were being younger adults (aged 18–29 years: OR = 1.52, 95% CI: 1.17–1.97; aged 30–39 years: OR = 1.39, 95% CI: 1.08–1.78), being farmers (OR = 1.61; 95% CI: 1.32–1.96), being unemployed people (OR = 1.36; 95% CI: 1.04–1.78), living in suburban areas (OR = 2.18; 95% CI: 1.89–2.51), having ≥2 children in the family (OR = 1.41; 95% CI: 1.03–1.92), perceived risk in China (OR = 1.30; 95% CI: 1.15–1.48), perceived susceptibility to disease (OR = 3.13; 95% CI: 2.73–3.58), perceived negative effect on daily life (OR = 1.32; 95% CI: 1.13–1.55), perceived effectiveness of vaccination (OR = 2.34; 95% CI: 2.07–2.64), and recent uptake of influenza vaccine (OR = 2.26; 95% CI: 1.92–2.66). CONCLUSIONS: A great number of Beijing residents had doubts about the vaccine’s effectiveness and were not concerned about disease risk, which were the factors affecting willingness to be vaccinated. Targeted education programs on disease risk as well as vaccine’s effectiveness are needed to improve the willingness of vaccination for potential H7N9 pandemic preparedness. Elsevier Ltd. 2018-01-25 2017-12-13 /pmc/articles/PMC7115431/ /pubmed/29246476 http://dx.doi.org/10.1016/j.vaccine.2017.12.008 Text en © 2017 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wu, Shuangsheng
Su, Jianting
Yang, Peng
Zhang, Haiyan
Li, Hongjun
Chu, Yanhui
Hua, Weiyu
Li, Chao
Tang, Yaqing
Wang, Quanyi
Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China
title Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China
title_full Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China
title_fullStr Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China
title_full_unstemmed Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China
title_short Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China
title_sort willingness to accept a future influenza a(h7n9) vaccine in beijing, china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115431/
https://www.ncbi.nlm.nih.gov/pubmed/29246476
http://dx.doi.org/10.1016/j.vaccine.2017.12.008
work_keys_str_mv AT wushuangsheng willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT sujianting willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT yangpeng willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT zhanghaiyan willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT lihongjun willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT chuyanhui willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT huaweiyu willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT lichao willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT tangyaqing willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina
AT wangquanyi willingnesstoacceptafutureinfluenzaah7n9vaccineinbeijingchina